Westlake
WLK
61.52
-1.87
-2.95%
Westlake
US · WLK
#1657 by market cap
Listed 1970
61.52
-1.87
-2.95%
Live - 5344 symbols - heartbeat 292s ago
· 2026-10-07 19:54
After-hours
61.52
0.00%
- Market cap
- 7.86B
- P/E (TTM)i
- -6.42
- P/Bi
- 0.90
- EPSi
- -11.70
- Div yieldi
- 3.45%
- 52W posi
- 10%
Reader sentiment
Are you bullish or bearish on WLK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.78, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.01% YoY
Margins
- Gross margin
- 7.28%
- Operating margin
- -1.89%
- Net margin
- -13.44%
Key ratios & quality
- Enterprise valuei
- 10.66B
- Altman Z-Scorei
- 1.78
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.64B | 8.12B | 7.50B | 11.78B | 15.79B | 12.55B | 12.14B | 11.17B |
| Gross profit | 1.99B | 1.26B | 1.02B | 3.50B | 4.07B | 2.22B | 1.96B | 813.00M |
| Selling & admin expenses | 445.00M | 458.00M | 435.00M | 528.00M | 809.00M | 865.00M | 874.00M | 900.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.44B | 693.00M | 479.00M | 2.84B | 3.11B | 1.23B | 966.00M | -211.00M |
| Pretax profit | 1.33B | 570.00M | 331.00M | 2.68B | 2.95B | 700.00M | 938.00M | -1.60B |
| Tax | 300.00M | 108.00M | -42.00M | 607.00M | 649.00M | 178.00M | 291.00M | -126.00M |
| Net profit | 1.03B | 462.00M | 373.00M | 2.07B | 2.30B | 522.00M | 647.00M | -1.47B |
| Basic EPS | 8 | 3 | 3 | 16 | 17 | 4 | 5 | -12 |
| Diluted EPS | 7.62 | 3.25 | 2.56 | 15.58 | 17.34 | 3.70 | 4.64 | -11.70 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.85B | 2.95B | 2.84B | 2.53B | 2.65B | 3.27B |
| Gross profit | 232.00M | 258.00M | 236.00M | 87.00M | 112.00M | 652.00M |
| Selling & admin expenses | 227.00M | 221.00M | 228.00M | 224.00M | 236.00M | 253.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -25.00M | 6.00M | -22.00M | -170.00M | -154.00M | 367.00M |
| Pretax profit | -34.00M | -125.00M | -775.00M | -663.00M | -190.00M | 338.00M |
| Tax | 1.00M | 6.00M | -3.00M | -130.00M | -33.00M | 67.00M |
| Net profit | -35.00M | -131.00M | -772.00M | -533.00M | -157.00M | 271.00M |
| Basic EPS | 0 | -1 | -6 | -4 | -1 | 2 |
| Diluted EPS | -0.31 | -1.11 | -6.06 | -4.22 | -1.31 | 2.01 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.84B | 2.74B | 3.48B | 5.26B | 5.97B | 6.61B | 6.21B | 6.22B |
| Cash & ST investments | 753.00M | 728.00M | 1.31B | 1.91B | 2.23B | 3.30B | 2.92B | 2.93B |
| Inventory | 1.01B | 936.00M | 918.00M | 1.41B | 1.87B | 1.62B | 1.70B | 1.65B |
| Total assets | 11.60B | 13.26B | 13.84B | 18.46B | 20.55B | 21.04B | 20.75B | 19.96B |
| Total current liabilities | 1.18B | 1.24B | 1.36B | 2.34B | 2.30B | 2.79B | 2.22B | 2.77B |
| Short-term debt | -- | -- | -- | 269.00M | -- | 299.00M | 134.00M | 635.00M |
| Long-term debt | 2.67B | 3.45B | 3.57B | 4.91B | 4.88B | 4.61B | 4.56B | 5.09B |
| Total liabilities | 5,526,000,000.00 | 6,858,000,000.00 | 7,257,000,000.00 | 9,931,000,000.00 | 10,085,000,000.00 | 10,271,000,000.00 | 9,707,000,000.00 | 10,666,000,000.00 |
| Total equity | 6.08B | 6.40B | 6.58B | 8.53B | 10.47B | 10.76B | 11.04B | 9.30B |
| Retained earnings | 5.48B | 5.76B | 5.94B | 7.81B | 9.89B | 10.14B | 10.48B | 8.70B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.02B | 5.95B | 5.75B | 6.22B | 5.95B | 5.69B |
| Cash & ST investments | 2.48B | 2.28B | 2.13B | 2.93B | 2.48B | 1.85B |
| Inventory | 1.78B | 1.73B | 1.73B | 1.65B | 1.68B | 1.75B |
| Total assets | 20.71B | 20.81B | 19.81B | 19.96B | 19.71B | 19.44B |
| Total current liabilities | 2.29B | 2.40B | 2.90B | 2.77B | 2.74B | 2.32B |
| Short-term debt | 232.00M | 232.00M | 750.00M | 635.00M | 670.00M | 128.00M |
| Long-term debt | 4.59B | 4.65B | 3.91B | 5.09B | 5.07B | 5.07B |
| Total liabilities | 9,790,000,000.00 | 10,015,000,000.00 | 9,876,000,000.00 | 10,666,000,000.00 | 10,656,000,000.00 | 10,231,000,000.00 |
| Total equity | 10.92B | 10.79B | 9.94B | 9.30B | 9.05B | 9.21B |
| Retained earnings | 10.37B | 10.16B | 9.31B | 8.70B | 8.46B | 8.66B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.41B | 1.30B | 1.30B | 2.39B | 3.40B | 2.34B | 1.31B | 465.00M |
| Depreciation & amortization | 641.00M | 713.00M | 773.00M | 840.00M | 1.06B | 1.10B | 1.11B | 1.18B |
| Free cash flow | 707.00M | 514.00M | 772.00M | 1.74B | 2.29B | 1.30B | 306.00M | -530.00M |
| Dividends paid | -120.00M | -132.00M | -137.00M | -145.00M | -169.00M | -221.00M | -264.00M | -272.00M |
| Stock buybacks / issuance | -106.00M | 33.00M | -54.00M | -30.00M | -101.00M | -23.00M | -60.00M | -63.00M |
| Ending cash balance | 775.00M | 750.00M | 1.34B | 1.94B | 2.25B | 3.32B | 2.94B | 2.74B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -77.00M | 135.00M | 182.00M | 225.00M | -94.00M | 318.00M |
| Depreciation & amortization | 283.00M | 295.00M | 303.00M | 297.00M | 284.00M | 286.00M |
| Free cash flow | -325.00M | -132.00M | -57.00M | -16.00M | -303.00M | 111.00M |
| Dividends paid | -68.00M | -68.00M | -68.00M | -68.00M | -68.00M | -69.00M |
| Stock buybacks / issuance | -30.00M | 0 | 0 | -33.00M | 0 | -30.00M |
| Ending cash balance | 2.31B | 2.10B | 1.94B | 2.74B | 2.29B | 1.66B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.94 | 7.35 | 5.53 | 28.65 | 24.99 | 4.72 | 5.77 | -15.54 |
| ROA %i | 8.37 | 3.39 | 2.43 | 12.42 | 11.46 | 2.29 | 2.87 | -7.37 |
| ROIC %i | 13.24 | 5.64 | 4.30 | 17.90 | 16.44 | 3.82 | 3.82 | -9.26 |
| 5-year avg ROE %i | 21.58 | 17.97 | 14.91 | 18.30 | 17.09 | 14.24 | 13.93 | 9.72 |
| EBIT margin %i | 16.91 | 8.55 | 6.30 | 24.22 | 19.77 | 6.89 | 9.03 | -12.77 |
| FCF / sales %i | 8.19 | 6.33 | 10.29 | 14.74 | 14.48 | 10.38 | 2.52 | -- |
| Current ratioi | 2.40 | 2.21 | 2.56 | 2.25 | 2.60 | 2.37 | 2.80 | 2.24 |
| Quick ratioi | 1.51 | 1.42 | 1.86 | 1.61 | 1.75 | 1.76 | 1.98 | 1.60 |
| Debt / assetsi | 23.00 | 28.66 | 28.49 | 30.56 | 26.19 | 26.23 | 26.04 | 32.11 |
| LT debt / equityi | 47.73 | 64.85 | 65.23 | 67.53 | 54.20 | 50.95 | 50.05 | 65.68 |
| Interest coveragei | 11.59 | 5.60 | 3.33 | 16.21 | 17.64 | 5.24 | 6.90 | -8.34 |
| Revenue CAGR (3Y) %i | 24.61 | 16.94 | -2.28 | 10.90 | 24.84 | 18.69 | 1.02 | -10.90 |
| Net income CAGR (3Y) %i | 15.52 | 1.81 | -36.75 | 26.48 | 74.76 | 13.22 | -33.15 | -- |
| FCF CAGR (3Y) %i | 6.34 | 29.26 | -6.71 | 34.91 | 64.48 | 19.03 | -43.93 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.72 | -0.64 | -9.48 | -15.54 | -17.19 | -12.95 |
| ROA %i | 1.85 | -0.32 | -4.65 | -7.37 | -8.06 | -6.11 |
| ROIC %i | 2.49 | -0.27 | -5.79 | -9.26 | -10.01 | -7.48 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.90 | 2.37 | -5.91 | -12.77 | -14.26 | -9.62 |
| FCF / sales %i | 0.70 | -- | -- | -- | -- | -- |
| Current ratioi | 2.64 | 2.47 | 1.99 | 2.24 | 2.17 | 2.45 |
| Quick ratioi | 1.81 | 1.71 | 1.34 | 1.60 | 1.52 | 1.65 |
| Debt / assetsi | 26.81 | 27.00 | 27.08 | 32.11 | 32.56 | 30.23 |
| LT debt / equityi | 51.10 | 52.39 | 48.96 | 65.68 | 67.23 | 66.03 |
| Interest coveragei | 5.25 | 1.78 | -4.27 | -8.34 | -8.32 | -5.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Performance and Essential Materials is the largest reported line at 65.79% of revenue, across 3 reported segments.
- Housing and Infrastructure Products follows at 38.28%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Performance and Essential Materials65.79%
Housing and Infrastructure Products38.28%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.